10-23439844-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001145373.3(OTUD1):c.387C>T(p.Pro129Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00218 in 1,121,446 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 29 hom., cov: 32)
Exomes 𝑓: 0.00085 ( 21 hom. )
Consequence
OTUD1
NM_001145373.3 synonymous
NM_001145373.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.500
Genes affected
OTUD1 (HGNC:27346): (OTU deubiquitinase 1) Deubiquitinating enzymes (DUBs; see MIM 603478) are proteases that specifically cleave ubiquitin (MIM 191339) linkages, negating the action of ubiquitin ligases. DUBA7 belongs to a DUB subfamily characterized by an ovarian tumor (OTU) domain.[supplied by OMIM, May 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 10-23439844-C-T is Benign according to our data. Variant chr10-23439844-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 776500.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.5 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0109 (1610/148166) while in subpopulation AFR AF= 0.0363 (1491/41112). AF 95% confidence interval is 0.0347. There are 29 homozygotes in gnomad4. There are 745 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 29 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTUD1 | NM_001145373.3 | c.387C>T | p.Pro129Pro | synonymous_variant | 1/1 | ENST00000376495.5 | NP_001138845.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTUD1 | ENST00000376495.5 | c.387C>T | p.Pro129Pro | synonymous_variant | 1/1 | 6 | NM_001145373.3 | ENSP00000365678.3 | ||
ENSG00000287124 | ENST00000702412.1 | n.88+799C>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0108 AC: 1602AN: 148058Hom.: 29 Cov.: 32
GnomAD3 genomes
AF:
AC:
1602
AN:
148058
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000712 AC: 7AN: 9832Hom.: 0 AF XY: 0.000681 AC XY: 4AN XY: 5870
GnomAD3 exomes
AF:
AC:
7
AN:
9832
Hom.:
AF XY:
AC XY:
4
AN XY:
5870
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000853 AC: 830AN: 973280Hom.: 21 Cov.: 30 AF XY: 0.000729 AC XY: 339AN XY: 464848
GnomAD4 exome
AF:
AC:
830
AN:
973280
Hom.:
Cov.:
30
AF XY:
AC XY:
339
AN XY:
464848
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0109 AC: 1610AN: 148166Hom.: 29 Cov.: 32 AF XY: 0.0103 AC XY: 745AN XY: 72222
GnomAD4 genome
AF:
AC:
1610
AN:
148166
Hom.:
Cov.:
32
AF XY:
AC XY:
745
AN XY:
72222
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
7
AN:
3034
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 26, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at